Haleon (NYSE:HLN) Stock Rating Lowered by Sanford C. Bernstein

Sanford C. Bernstein downgraded shares of Haleon (NYSE:HLN) from an outperform rating to a market perform rating in a research note published on Wednesday, Marketbeat.com reports.

Several other research analysts also recently commented on the stock. Morgan Stanley lifted their target price on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research note on Friday, September 20th. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Haleon has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Stock Performance

Haleon stock opened at $9.50 on Wednesday. The firm has a fifty day simple moving average of $9.61 and a two-hundred day simple moving average of $9.67. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a market capitalization of $43.00 billion, a PE ratio of 27.94, a P/E/G ratio of 2.95 and a beta of 0.29.

Institutional Trading of Haleon

Hedge funds have recently made changes to their positions in the stock. FMR LLC increased its position in Haleon by 5.8% during the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after buying an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC increased its holdings in shares of Haleon by 8.6% during the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after acquiring an additional 3,307,009 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Haleon by 49.9% in the 3rd quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock worth $96,833,000 after purchasing an additional 3,046,841 shares during the last quarter. Sculptor Capital LP raised its position in shares of Haleon by 67.8% in the 2nd quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after purchasing an additional 3,592,000 shares during the last quarter. Finally, Douglas Lane & Associates LLC grew its position in Haleon by 1.9% during the 4th quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock valued at $82,274,000 after purchasing an additional 161,865 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.